Pages

.

Salutron, Inc. Introduces Its New LifeTrak App

FREMONT, Calif., May 22, 2014 /PRNewswire/ -- Salutron, Inc., the foremost leader in heart-rate monitoring and precise biometric data acquisition, today introduced its new LifeTrak app for both Android and iOs – a breakthrough app that provides a comprehensive view of your health and fitness vitals. The LifeTrak app syncs with your LifeTrak Zone C410 or LifeTrak Move C300 device to give you a deeper understanding of your activity, sleep patterns and most importantly your overall well-being – giving you more motivation to stay on track with a healthy lifestyle.

Synchronizing data between your LifeTrak activity tracker and your smartphone has never been easier with the new LifeTrak app. The app gives you more detailed, 24/7 insight into data trends on a daily, weekly, and yearly basis and provides easy-to-read data graphs that keep you organized and motivated toward your health and fitness goals.

Knowing and tracking your heart rate is the most important step toward improving your overall well-being, which is why LifeTrak's line of activity trackers help you "Follow your Heart" to a better lifestyle. LifeTrak activity monitors incorporate heart rate and physical motion into the calorie burn calculation, which is considered a more precise way to determine calorie expenditure. They also provide the most sophisticated science and accurate data calculation of any activity tracker on the market, giving users the ability to make more informed changes to their health.

The combination of the LifeTrak app working in tandem with its activity trackers makes the experience of personal health and fitness monitoring uniquely efficient and automated. LifeTrak activity trackers allow users to track all of their vitals (including sleep) and view up to 7 days of data, right on their wrists. With the LifeTrak app, users can extend the data storage capabilities to weeks, months or years. Additional features of the LifeTrak app include:

Fitness dashboard with intuitive graphical progress circle- heart rate, steps, distance, calories, active time, sleep, and workout See your data trends, goals and progress at a hourly, daily, weekly, monthly and yearly level Rotate to landscape for one, detailed chart that integrates heart rate, steps, calories and distance Precise Actigraphy – Displays active time, sedentary time, and sleep time details Ability to sync with your LifeTrak activity tracker at a press of the button"We are very proud of the customer response to our popular line of LifeTrak activity trackers, so introducing this new app was a natural next step for us," said Mike Tsai, CEO of Salutron. "Adding the LifeTrak app to our portfolio only serves to enhance our ability to provide a fully automated, ubiquitous experience for our customers, so that they can easily attain a healthier lifestyle."  

LifeTrak is a free app available today for both Android and iPhone devices. To download the app and check device compatibility, visit www.lifetrakusa.com/app or follow us on Twitter and Facebook.

About Salutron, Inc.

Salutron, Inc., is an industry leader in heart rate monitoring technology for fitness and health equipment and products. Found in gyms across the globe, the company's technology is incorporated into many name brands including, Precor, Nautilus, Star Trac, and Life Fitness. From the gym to your wrist, Salutron also offers accurate, durable and connected wearable devices for physiological monitoring on-the-go.

The wearable devices, in band and watch format, are branded under LifeTrak and SmartHealth.  Salutron technology has also been incorporated into many well-known private label brands including Timex, Reebok, New Balance, Sportline and Pro-Form.  Products with Salutron's technology can be found in major retailers including Sports Authority, Sport Chalet, Dick's Sporting Goods, Big 5, Best Buy, RadioShack, Frys, Target, Walmart, Walgreens, CVS, Costco, and Amazon.  

Additionally, Salutron develops physiological monitoring products for government agencies like DARPA, NASA, the US Army, and brings those innovative technologies to the everyday consumer. Salutron is privately held and based in Fremont, CA.  More information on Salutron and LifeTrak products can be found at lifetrakusa.com or follow @MyLifeTrak.

Media Contact for Salutron:

April Mayrath
Consort Partners
salutron@consortpartners.com
Tel: +1 210 323 7018  

SOURCE Salutron, Inc.

RELATED LINKS
http://www.lifetrakusa.com

reade more... Résuméabuiyad

Xencor to Present at Jefferies 2014 Global Healthcare Conference

MONROVIA, Calif., May 22, 2014 /PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, today announced that Bassil Dahiyat, Ph.D., president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Thursday, June 5, 2014 at 8:00 a.m. EDT in New York City, NY.

A live audio webcast of the presentation will be available on the "Events and Presentations" section in the Investors section of the company's website located at http://investors.xencor.com/events.cfm. A replay of the presentation will be posted on the Xencor website approximately one hour after the event and will be available for 30 days following the presentation.

About Xencor, Inc.
Xencor is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Currently, six candidates are in clinical development internally and with partners that have been engineered with Xencor's XmAb® technology. Xencor's internally-discovered programs include XmAb5871 in Phase 1b/2a clinical trials for the treatment of Rheumatoid arthritis and lupus, XmAb7195 in preclinical development for the treatment of asthma, and XmAb5574/MOR208 which has been licensed to Morphosys AG and is in Phase 2 clinical trials for the treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma. Xencor's XmAb antibody engineering technology enables small changes to the structure of monoclonal antibodies resulting in new mechanisms of therapeutic action. Xencor partners include Amgen, Merck, Janssen R&D LLC, Alexion and Boehringer Ingelheim.

For more information, please visit www.xencor.com.

SOURCE Xencor

RELATED LINKS
http://www.xencor.com

reade more... Résuméabuiyad

ClinCapture 2.0 Official Launch on May 23rd

SUNNYVALE, Calif., May 20, 2014 /PRNewswire-iReach/ -- On May 23rd at 10am PST Marc Desgrousilliers, Chief Technology Officer at Clinovo, will introduce the new 2.0 version of ClinCapture, the most advanced open source Electronic Data Capture (EDC) system. Marc will give a one-hour online demonstration of the new features in ClinCapture 2.0. He will focus on ClinCapture's new On Demand Trainings, Rules Studio, and Interactive Dashboards. Registration for the webinar is now open on clinovo.com/clincapture2.

The 2.0 ClinCapture release includes a new Rules Studio to create edit checks within the EDC system without XML programming. The Rules Studio does not require any specific training or IT expertise.ClinCapture 2.0 becomes the first open source EDC system with a fully integrated drag-and-drop edit check builder.

The new Interactive Dashboards give users a graphical overview of essential metrics directly from ClinCapture's homepage. Users can quickly dip in and out of their clinical data to manage different clinical sites or monitor new queries. The dashboards are easily customizable thanks to the drag-and-drop interface.

ClinCapture 2.0 features online self-paced On Demand Trainings. The convenience of online format accelerates the adoption of ClinCapture worldwide and helps facilitate the learning curve. "The online trainings save the time of flying out trainers, and thus break down the barrier to learning ClinCapture in different time zones," explains Danny Lieberman, CEO of Israel-based Clear Clinica.

The release comes with a series of additional enhancements, making ClinCapture more user-friendly coupled with increased capability. In particular, the extended import and export capabilities make the extracted data directly readable in SAS. The migration of data from another EDC system to ClinCapture is also simplified by this enhanced import capability.

The Clinovo team will showcase ClinCapture 2.0 at major industry conferences in the weeks following the online launch. Clinovo will be presenting its flagship EDC system at the Partnerships in Medical Device Conference from June 2nd to 4th in Chicago (IL), and DIA from June 15th to 19th in San Diego (CA).

Since its launch in 2008, ClinCapture has been deployed for clinical studies from five patients to tens of thousands of patients. Three sponsor companies have secured FDA approvals using ClinCapture as their preferred Electronic Data Capture (EDC) system. A 30-day evaluation of ClinCapture can be started on clinovo.com/clincapture.

Contact information 
Sophie McCallum 
Director of Operations, Clinovo 
408-773-6258 
sophie.mccallum(at)clinovo(dot)com

About Clinovo

Clinovo is a technology focused Contract Research Organization (CRO) headquartered in the Silicon Valley. Clinovo streamlines clinical trials for life science companies globally by developing validated, intuitive open source eClinical Systems. Clients claim over 50% cost savings using Clinovo's open source Electronic Data Capture (EDC) system ClinCapture, and CDISC Express, the first open source CDISC conversion tool. Services also include Clinical Data Services, Staffing Solutions, and TechTrainings.

Media Contact: Sophie McCallum, Clinovo, 4087736258, sophie.mccallum@clinovo.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Clinovo

RELATED LINKS
http://www.clinovo.com

reade more... Résuméabuiyad

Medbox Chief Executive Officer to Appear on Bloomberg TV's "In the Loop with Betty Liu" on May 20, 2014

LOS ANGELES, May 20, 2014 /PRNewswire-USNewswire/ -- Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), a leader in providing ancillary services to the alternative medicine industry, dispensary consulting services, and patented medicine dispensing systems to medical and retail industries, today announced that Dr. Bruce Bedrick, chief executive officer of Medbox, will appear on Bloomberg TV's "In the Loop with Betty Liu" on May 20, 2014 at 9:35 am ET. 

Dr. Bedrick has been invited to appear to discuss Medbox and its dispensing and storage systems, along with recent headlines regarding the legalized business of marijuana. Medbox is the industry leader in the legal marijuana industry. The Company has consulted with more than 400 clients in six states, helping businesses secure licenses, identify locations, build-out dispensaries, educate patients and conduct business in a safe, secure, and legally compliant way. 

About Betty Liu:

Betty Liu is editor-at-large for Bloomberg Television and the host of "In the Loop with Betty Liu," a weekday program providing the fastest and most comprehensive coverage of the headlines and major events set to shape the business day ahead. She also hosts "In the Loop, At the Half" on Bloomberg Radio, airing weekdays at noon. An award-winning business journalist, Liu regularly interviews influential business, political and media leaders including Warren Buffett, Carlos Slim, Ted Turner and Lloyd Blankfein. Before joining Bloomberg Television, Liu served as an anchor for CNBC Asia based in Hong Kong. Prior to that, she was the Atlanta bureau chief for the Financial Times. Earlier in her career, Liu was the Taiwan bureau chief for Dow Jones Newswires - the youngest ever in Asia - and a Hong Kong-based regional correspondent for the newswire. In 1997, she received a Dow Jones Newswires Award for her coverage of the Asian financial crisis.

About Medbox, Inc.:? 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws.? Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control.? In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change.? Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation.? We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Medbox, Inc. is a publicly traded company, and is quoted on the OTCQB, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medbox.com. 

Contacts: 

Investors 
Stephen Hart 
Hayden IR 
+1- 917-658-7878 
hart@haydenir.com 

SOURCE Medbox, Inc.

RELATED LINKS
http://www.medbox.com

reade more... Résuméabuiyad

Retailer Keeps Loss Prevention Low and Customer Satisfaction High with DigitalPersona Fingerprint Solution

Trusted partner for biometric identity verification solutions. (PRNewsFoto/DigitalPersona, Inc.)jwplayer.key="2kY/GKwZ2uQZmDlQ9VYArfZt2b4+KhHX3+DM4zisgtE=";REDWOOD CITY, Calif., May 21, 2014 /PRNewswire/ -- DigitalPersona, Inc., a trusted partner for biometric identity verification solutions, today announced that  New Look, a leading China fashion retailer, has selected a Point-of-Sale (POS) system enabled with DigitalPersona® fingerprint technology. After a successful trial at six of the retailer's stores in February 2014, New Look is set to expand their use of biometrics in 16 of its stores by the end of 2014 — with longer-range plans to equip 100 stores by 2017. The retailer initially selected biometric technology as an alternative to passwords for improving time and attendance accuracy, but found it also enhances loss prevention and customer service.

Each New Look store has two to four POS terminals depending on the store size, which are shared by the retailer's employees. In the past, the potential for employees to clock in for each other existed, increasing the risk of payroll fraud. Prior to adopting fingerprint biometrics, New Look implemented six-digit passwords to enhance security. However, passwords were cumbersome for employees to remember and had to be changed every 90 days to meet security standards. As a result, the IT department at New Look's UK-based headquarters saw an uptick in the number of calls to reset forgotten passwords.

New Look employees now use their fingerprints to clock in and log on to the POS terminals, providing a more secure alternative to passwords. In turn, store managers and deputy managers must use their fingerprints to approve returns, discounts and overrides.

"We have seen customer service levels improve because employees are more efficient since they no longer have to remember complex passwords," said Sky Shen, senior IT consultant at New Look. "Biometrics has helped us stay below our one percent loss prevention standard since fingerprints are also now used for management authorization of overrides."

Incorporating biometrics to confirm positive identity creates a business advantage for retailers, such as New Look, which hopes to attract more franchise owners and open more stores as part of its expansion plans in China. New Look China is also considering recommending deployment at their UK headquarters.  

"DigitalPersona's biometric solutions are assisting retailers worldwide in their efforts to reduce fraud, keep loss prevention rates low and improve customer service," said Richard Agostinelli, DigitalPersona president and CEO. "We're very pleased with the success that New Look, through their partnership with Cegid Group, has experienced with our technology and look forward to their continued growth."

See DigitalPersona at Retail Asia Expo in Cegid Group Booth #L35, June 10-12 in Hong Kong.

About DigitalPersona
DigitalPersona offers the world's broadest portfolio of biometrics-based identity verification solutions. Applications range from highly secure banking environments and complex government identity programs to point-of-sale retail systems. Our solutions verify the identity of more than 200 million authorized users worldwide and significantly reduce the risk of fraud, theft and unauthorized access. Offerings for end-users and system integrators include industry-specific software applications, complete SDKs and a full range of optical, silicon, touch, swipe and embedded readers.  For more information call +1 650.474.4000 or send an email to pr@digitalpersona.com.

© 2014 DigitalPersona, Inc. All rights reserved. DigitalPersona® is a trademark of DigitalPersona, Inc. registered in the United States and other countries. All other trademarks are the property of their respective owners. 

Logo - http://photos.prnewswire.com/prnh/20140515/88123

SOURCE DigitalPersona, Inc.

RELATED LINKS
http://www.digitalpersona.com

reade more... Résuméabuiyad

Texas' Biocorridor continues to grow exponentially with addition of mixed use community

BRYAN/COLLEGE STATION, Texas, May 19, 2014 /PRNewswire/ -- ATLAS is the first master planned community in Texas designed for companies engaged in manufacturing biologics and pharmaceuticals.

Less than two miles from Texas A&M University, ATLAS offers a prime location for a community with an amenity-rich lifestyle and the collaborative atmosphere companies need with access to world-class researchers and students.

ATLAS will provide a vibrant, walkable lifestyle for the people relocating to Bryan/College Station to work in the biotech and pharmaceutical labs and offices.  

Texas A&M is under construction on the newly formed Center for Innovation in Advanced Development and Manufacturing (CIADM). The first component is a $91 million facility operated by KALON Biotherapeutics that will manufacture a Glaxo Smith Kline product and provide a national response capability in the event of a pandemic.

This national asset is situated near Caliber Biotherapeutics, the world's largest plant-based vaccine manufacturing facility. Also under construction is the global headquarters for Nutrabolt, the maker of Cellucor nutrition products.

An important part of the experience within ATLAS is a thriving town center where residents and guests can walk to Lake Atlas and enjoy the inviting green space. Also in planning are a boutique hotel, retail, waterfront restaurants, and a live music venue. ATLAS also has direct access to amenities of Traditions Club, which features a Nicklaus designed golf course and is home to the Texas A&M golf teams.

"We are developing ATLAS specifically for life-science manufacturers who want to position their companies and people in a truly integrated community where it's possible to work, collaborate, live and recreate, all at the epicenter of the region's burgeoning One Health Plus Biocorridor," stated Spencer Clements, Principal, Traditions Acquisition Partnership, developer of Atlas and The Traditions Club and Community.

"To successfully attract additional biotech industry, our quality of life amenities have to be competitive," College Station Mayor, Nancy Berry said.

"As the biocorridor grows, this entire region of Texas will benefit," echoed Bryan, Texas Mayor, Jason Bienski. "To see BCS and the Research Valley become the new biotech development area of choice is truly exciting."

"The Atlas announcement represents another brilliant step in accomplishing the Biocorridor vision. We are honored to work day in and day out with a development partner that desires to compete with us on the global playing field. I know Atlas will be world-class." stated Todd E. McDaniel, President & CEO, The Research Valley Partnership, Inc.

For more information, atlastx.com

SOURCE Atlas, Texas; Biocorridor

reade more... Résuméabuiyad

IBM Receives Frost & Sullivan Customer Value Leadership Award for its Mobile Identity and Access Management Solutions

MOUNTAIN VIEW, Calif., May 20, 2014 /PRNewswire/ -- Based on its recent analysis of mobile authentication, Frost & Sullivan recognizes IBM with the 2014 Global Frost & Sullivan Award for Customer Value Leadership. Central to the company's success in generating value for customers is the integration of various mobile security, mobile identity, and access management solutions. IBM's strong value proposition with regards to the provisioning of context-based authentication for multiple mobile device types and mobile applications has also been instrumental to its success.

"When it comes to identity and access management, organizations often face a trade-off between improving security levels and delivering greater end-user convenience," said Frost & Sullivan Senior Industry Analyst Mario Fernandez. "IBM breaks the security/end-user convenience trade-off through its IBM Security Access Manager for Mobile appliance."

The IBM Security Access Manager for Mobile appliance's risk engine determines the risk of an end user's authentication attempt by comparing it with a historical behavior profile of that user, which contains information related to the volume, type and frequency of transactions; Internet protocol reputation; geographic location; and device fingerprinting. On ascertaining the risk, the appropriate authentication method is applied. While low-risk access attempts require simple authentication methods such as a password, high-risk access attempts might involve hardware or software one-time password tokens.

To determine the appropriate authentication method, the IBM Security Access Manager for Mobile risk engine also pays heed to the application or data that the end user wants to access. For instance, if an end user wants to access a business-critical application or confidential data, then they must use an authentication method with a high degree of irrefutability. Essentially then, security becomes context-based and organizations can establish—and seamlessly enforce—access management policies without introducing greater end-user inconvenience.

The value proposition of IBM's Security Access Manager for Mobile appliance is enhanced through the integration of other IBM products, including IBM Security Access Manager for Web, which adds content security capabilities to protect against attacks such as SQL injection and cross-site scripting. Likewise, IBM's Federated Identity Manager, which supports the Security Assertion Markup Language (SAML), WS-Federation and OpenID standard protocols, can enable federated single sign-on. This facilitates the integration of cloud services, such as Google Apps or Office 365, which also support the above-mentioned protocols.

In a bid to remain ahead of its competitors, IBM added two important security companies and their corresponding products to its portfolio in 2013—Trusteer and Fiberlink. The company has also drawn up a future-proof product roadmap that recognizes that biometric authentication methods and contactless technologies will play a prominent role in enabling mobile access.

"Already, IBM's scientists have developed an algorithm to determine biometric-based authentication risk scores and risk analysis that can be incorporated into IBM Security Access Manager for Mobile," said Fernandez.

Each year, Frost & Sullivan presents this award to the company that demonstrates excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. This award recognizes the company's inordinate focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and, ultimately, customer base expansion.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About IBM Security

IBM Security offers one of the most advanced and integrated portfolios of enterprise security products and services. The portfolio, supported by world-renowned IBM X-Force research and development, provides the security intelligence to help organizations protect their people, data, applications and infrastructure. IBM offers security solutions for identity and access management,  database security, application development, risk management, endpoint management, next-generation intrusion protection and more. IBM operates one of the world's broadest security research and development, and delivery organizations. IBM monitors 15 billion security events per day in more than 130 countries and holds more than 3,000 security patents. For more information on IBM security solutions, X-Force reports, and webinars, please visit: www.ibm.com/security.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies? Contact us: Start the discussion.

Contact:

Mireya Espinoza
P: 210. 247.3870
F: 210.348.1003
E: mireya.espinoza@frost.com

Jacqueline McCouat
P: + 44 7768 504084
E: jacqueline.mccouat@uk.ibm.com

SOURCE Frost & Sullivan

RELATED LINKS
http://www.frost.com

reade more... Résuméabuiyad